Alpha Diagnostic International, Inc. Anti-Human p73 beta antiserum # 3 P73B13-S

Anti-Human p73 beta antiserum # 3 General Information Human p73 is the first known structural and functional homolog of one of the most studied tumor protein, p53 (1). Human p73 gene encodes two distinct polypeptides: The p73 long form (human 636 AA, termed p73 ; mouse 690 aa) and the short form (499 AA; t SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Human SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Antiserum Unpurified SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen An 8 amino acid peptide sequence (gene accession # BAB87245.1) (designated p73B13-P, control peptide) mapping at the C-terminus of human p73 (1) was used to generate anti-human p73 . The peptide was coupled with KLH (carrier protein) SpCrossreactivity The 8 AA human P73B13-P immunogenic peptide sequence has no significant homology with p73 . It is conserved in monkey p73. Antibody crossreactivity in various species is not established For research use only, not for diagnostic or therapeutic use.